WeChat Mini Program
Old Version Features

Safety and Efficacy of Etigilimab in Combination with Nivolumab in Select Recurrent/advanced Solid Tumors.

Journal of Clinical Oncology(2022)

Cited 2|Views27
Key words
Intratumor Heterogeneity
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined